Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
19 April 2021 | Story NONSINDISO QWABE | Photo Supplied
LLB graduate Tshepang Mahlatsi

 
‘Be loyal to your calling and the universe will locate you.’ This slogan is the mantra that University of the Free State LLM student, Tshepang Mahlatsi, lives by. It is also this slogan that carried him through a tumultuous journey during the pursuit of his LLB degree, which he received during the Bloemfontein Campus graduation ceremony on 19 April. 

Mahlatsi began his LLB degree in 2014, but he had to take a break from his academics in 2016 after being clinically diagnosed with depression. He obtained his qualification in 2020. Mahlatsi said 2016 was a year that started on a high note for him as a third-year Law student and newly elected prime for Tswelopele residence, but quickly took a downward dive when he found himself overwhelmed by leadership demands – coupled with the simultaneous loss of loved ones and constant academic pressure. It ultimately led to a breakdown, forcing him to put his studies on hold. "I am graduating with my LLB after life-changing events in my undergraduate years – from student politics, depression, and PTSD, to starting a mental-health organisation and using both CUADS and Kovsie Counselling support services to come back to ‘normalcy’.”

He said the year-long break from his studies left him feeling discouraged as he watched his peers and classmates progress and graduate. "It was the most difficult thing to do to remind myself that I wasn't stupid." 

"This journey exposed a lot about myself; it exposed that with determination and resilience, you can achieve what you set out to achieve. I had to persevere not because I wanted to, but because my family has never seen a graduate. I was doing this for them; to give them something they've never had,” he said. 

UFS support services can save lives 

Mahlatsi would like more students to make use of the UFS support services and not crumble under mental-health problems. "I hope to inspire students to use their support services and not be ashamed – services such as CUADS and Student Counselling and Development. I hope to inspire student leaders and students to realise that you can be a well-rounded student and still have challenges, but eventually, success awaits us all."

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept